Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

13:27 ET LPG SYSTEMS revela um grande avanço: As pacientes sujeitas a mastectomia com radiação podem beneficiar de uma reconstrução mamária minimamente invasiva

Um estudo piloto publicado no Breast Journal revela os benefícios de usar a Endermologia - uma marca registada da LPG SYSTEMS- na reconstrução...


13:22 ET LPG SYSTEMS kündigt einen bedeutenden Fortschritt an: Bestrahlte Mastektomiepatientinnen können minimalinvasive Brustrekonstruktion zu nutzen

Eine im Breast Journal veröffentlichte Studie zeigt die Vorteile der Nutzung von Endermologie – eine Handelsmarke von LPG SYSTEMS – bei...


13:00 ET New Report Calls for Measurement of Outcomes and Federal Funding for Research and Increased Capacity at FDA to Advance Safe and Effective Regenerative Cell Therapies

A new report released by the independent, non-profit Alliance for Cell Therapy Now, highlights the need for a national effort to measure outcomes...


12:00 ET EicOsis Announces First Subject Dosed in Phase 1a Clinical Trial of EC5026

EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase...


11:37 ET Clear Thoughts Foundation has created a new collaborative initiative to fund breakthrough discoveries for dementia research in 2020

It's a disease that has quietly become one of the leading causes of death in the U.S. and world today… dementia. Beginning in January 2020, the Clear ...


09:17 ET GIOSTAR in Process of US FDA Approval for Type 2 Diabetes Clinical Trial

Global Institute of Stem Cell Therapy and Research (GIOSTAR), the leader in regenerative technologies, is proud to announce that they are in the...


09:00 ET Prescient Medicine and Erasmus MC Partner to Study Opioid Addiction Risk

Prescient Medicine Holdings, Inc. and the Department of Clinical Chemistry at Erasmus MC (CC-EMC), Rotterdam today announced a partnership for CC-EMC ...


08:35 ET NCCN Announces Projects Funded for Metastatic Breast Cancer Grant Program, in Collaboration with Pfizer

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced the proposals that were selected to receive...


08:35 ET Eisai Presents New Analyses of Potential Blood-Based Alzheimer's Diagnostic Test and Lemborexant as Potential Sleep-Wake Disorder Therapy

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced that new data findings for two investigational assets in its robust...


08:30 ET Belong.Life Cancer Clinical Trial Matching Feature Surpasses 6,000 Suggested Patient Matches

Belong.Life, creator of the "Belong- Beating Cancer Together" mobile app, the world's largest interactive social network for cancer patients,...


08:30 ET U.S. FDA Grants VistaGen Therapeutics Fast Track Designation for PH94B for Treatment of Social Anxiety Disorder

VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system ...


08:18 ET Nurish.Me, a leader in highly advanced rejuvenation products, announces the release of the new and enhanced CogniNurish Pro, based on discoveries from the landmark Alzheimer's study and other clinical trials, for even greater efficacy.

Nurish.Me Inc. (Subsidiary - F/K/A Altavoz Entertainment, Inc.; OTC Pink: AVOZ) (the "Company") is an emerging leader in the dietary supplement...


08:08 ET Eisai to Present New Data on HALAVEN® (eribulin mesylate) Injection at 42nd Annual San Antonio Breast Cancer Symposium

Eisai announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (marketed as HALAVEN®) will...


08:01 ET WCG Launches AIMS 4.1 Platform with Enhanced Endpoint Adjudication Capabilities to Facilitate Expert Review of Clinical Trial Data

WCG ACI Clinical, the leading specialty provider of independent endpoint adjudication and data monitoring committees for clinical trials, has...


08:00 ET CNS Pharmaceuticals Received Positive FDA Pre-IND Guidance for Berubicin

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for...


07:56 ET DARZALEX® (Daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CANDOR study showing the addition of DARZALEX®...


07:37 ET TechMah Medical y LimaCorporate reciben la primera aprobación 510k para tecnología digital Smart SPACE

LimaCorporate se complace al anunciar la aprobación FDA 510K para Smart SPACE Shoulder 3D Planner & 3D Positioner. Smart SPACE es una innovadora...


07:30 ET Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Discover Dysplasias™, an initiative with BioMarin...


07:30 ET Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting

Amgen (NASDAQ:AMGN) today announced additional results from the primary analysis of the Phase 3 CANDOR study evaluating KYPROLIS® (carfilzomib) in...


07:19 ET Diverse Biotech takes big step toward a new class of oncology drug candidates with its proprietary CuSP-C2 conjugate synthesis platform

Diverse Biotech, Inc. www.diversebiotech.com has announced it has successfully synthesized and progressed into pre-clinical testing its first two new ...


07:01 ET MYOS to Introduce its Longevity Business with its Physician Muscle Health Formula at the World Congress on Anti-Aging Medicine in Las Vegas December 13-15, 2019

MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary...


07:00 ET Syndax Pharmaceuticals Announces Plans to Commence Phase 2 Expansion Cohort of SNDX-6352 for the Treatment of Chronic Graft Versus Host Disease

Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative...


07:00 ET A CartiHeal anuncia resultados positivos da análise provisória do estudo Agili-C™ IDE

A CartiHeal, desenvolvedora do Agili-C™, um implante proprietário para o tratamento de lesões de cartilagem em articulações artríticas e não...


06:00 ET Bloom Science Collaborates with Cedars-Sinai Medical Center to Expand Microbiome Research and Discovery into Brain Cancer

Bloom Science, a biopharmaceutical company developing microbiome-derived therapeutics in multiple neurological conditions and oncology, today...


03:00 ET Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines...